HPHA — Heidelberg Pharma AG Share News
0.000.00%
Last trade - 00:00- €120.70m
- €147.30m
- €1.46m
Brief: Heidelberg Pharma: Partner Telix Pharmaceuticals Files Phase III Trial For Kidney Cancer Imaging In Europe
Brief: Heidelberg Pharma H1 Net Loss Widens To EUR 4.7 Mln
Brief: Heidelberg Pharma Q1 Net Loss Widens To 2.4 Million Euros
Brief: Heidelberg Pharma FY Net Loss At EUR 11.0 Million
Brief: Magenta Therapeutics And Heidelberg Pharma Sign Agreement For Development Of Antibody Drug Conjugates
Brief: Heidelberg Pharma And Advanced Proteome Therapeutics Progress Collaborative Program
Brief: Heidelberg Pharma raises approx EUR 34.4 mln from capital measure
Brief: Heidelberg Pharma fixes subscription price of new shares at EUR 2.60 per share
Brief: Heidelberg Pharma plans capital measure to fund its ATAC development programs
Brief: Heidelberg Pharma: partner RedHill announces Orphan Drug Designation for MESUPRON
Brief: Wilex successfully completes change of name to Heidelberg Pharma AG
Brief: WILEX AG adjusts FY guidance
Brief: Wilex H1 sales revenue and income down at EUR 1.1 mln
Brief: Wilex says unit Heidelberg Pharma signs research agreement with Takeda
Brief: Wilex successfully completes rights issue
Brief: Wilex says plans rights issue using authorised capital
Brief: Wilex Q1 net loss widens to 2.0 million euros
Brief: Wilex posts FY net loss of 6.4 million euros
Nordic Nanovector sees interest in its Non-Hodgkin Lymphoma treatment (updated)